Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idex (IEX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Idex (IEX) over the last 17 years, with Q3 2025 value amounting to $593.8 million.

  • Idex's Cash & Equivalents fell 622.24% to $593.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $593.8 million, marking a year-over-year decrease of 622.24%. This contributed to the annual value of $620.8 million for FY2024, which is 1618.94% up from last year.
  • As of Q3 2025, Idex's Cash & Equivalents stood at $593.8 million, which was down 622.24% from $568.2 million recorded in Q2 2025.
  • Over the past 5 years, Idex's Cash & Equivalents peaked at $958.1 million during Q1 2021, and registered a low of $430.2 million during Q4 2022.
  • Its 5-year average for Cash & Equivalents is $638.3 million, with a median of $616.3 million in 2024.
  • As far as peak fluctuations go, Idex's Cash & Equivalents skyrocketed by 6832.57% in 2021, and later crashed by 4970.77% in 2022.
  • Idex's Cash & Equivalents (Quarter) stood at $855.4 million in 2021, then tumbled by 49.71% to $430.2 million in 2022, then increased by 24.2% to $534.3 million in 2023, then rose by 16.19% to $620.8 million in 2024, then fell by 4.35% to $593.8 million in 2025.
  • Its Cash & Equivalents stands at $593.8 million for Q3 2025, versus $568.2 million for Q2 2025 and $594.1 million for Q1 2025.